[1] Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli ( UPEC ) Infections : Virulence Factors , Bladder Responses , Antibiotic , and Non-antibiotic Antimicrobial Strategies. Front Microbiol. 2017;8:1566.
[2] Raeispour M, Ranjbar R. Antibiotic resistance , virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrob Resist Infect Control. 2018;7:118.
[3] Bien J, Sokolova O, Bozko P. Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage. Int J Nephrol. 2012;2012(Article ID 681473):doi: 10.1155/2012/687473.
[4] Calhau V, Domingues S, Mendonc N, Jorge G, Silva D, Jorge G, et al. Interplay between pathogenicity island carriage , resistance profile and plasmid acquisition in uropathogenic Escherichia coli. J Med Microbiol. 2015;64:828–35.
[5] Partridge SR, Kwong SM, Firth N, Jensen SO. Mobile Genetic Elements Associated with Antimicrobial Resistance. Clin Microbiol Rev. 2018;31(4):e00088-17.
[6] Yan F, Polk DB. Commensal bacteria in the gut: learning who our friends are. Curr Opin Gastroenterol. 2004;20(6):565–71.
[7] Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2:123–40.
[8] Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269–84.
[9] Düzgün AÖ, Okumuş F, Saral A, Çiçek AÇ, Cinemre S. Determination of antibiotic resistance genes and virulence factors in Escherichia coli isolated from Turkish patients with urinary tract infection. Rev Soc Bras Med Trop. 2019;52:e20180499.
[10] Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M, Bugla-Ploskonska G, et al. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: Recent reports. Gut Pathog. 2019;11:10.
[11] Ikram R, Psutka R, Carter A, Priest P. An outbreak of multi-drug resistant Escherichia coli urinary tract infection in an elderly population: A case-control study of risk factors. BMC Infect Dis. 2015;15:224.
[12] Lee DS, Lee SJ, Choe HS, Giacobbe DR. Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance. Biomed Res Int. 2018;(Article ID.7656752):https://doi.org/10.1155/2018/7656752.
[13] Alanazi MQ, Alqahtani FY, Aleanizy FS. An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: Retrospective study. Ann Clin Microbiol Antimicrob. 2018;17:3.
[14] O’Neill J. Tackling drug-reistant infections globally: final report and recommendations. The review on antimicrobial resistance. 2016.
[15] Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma-Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses : The PRISMA Statement. Plos Med. 2009;6(7):e1000097.
[16] O’Brien VP, Dorsey DA, Hannan TJ, Hultgren SJ. Host Restriction of Escherichia coli Recurrent Urinary Tract Infection Occurs in a Bacterial Strain-Specific Manner. PLoS Pathoges. 2018;14(12):e1007457.
[17] Centers for Disease Control and Prevention. Urinary Tract Infection ( Catheter-Associated Urinary Tract Infection [ CAUTI ] and Non-Catheter-Associated Urinary Tract Infection [ UTI ]) Events [Internet]. 2020 [cited 2020 Feb 20]. Available from: http://www.cdc.gov/nhsn/PDFs/pscManual/7pscCAUTIcurrent.pdf
[18] Nyaga VN, Arbyn M, Aerts M. Metaprop : a Stata command to perform meta-analysis of binomial data. Arch Public Heal. 2014;(72):39.
[19] Hunter JP, Saratzis A, Sutton AJ, Boucher RH, Sayers RD, Bown MH. In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias. J Clin Epidemiol. 2014;67(8):897–903.
[20] Ghazvini H, Taheri K, Edalati E, Sedighi M, Mirkalantari S. Virulence factors and antimicrobial resistance in uropathogenic Escherichia coli strains isolated from cystitis and pyelonephritis. Turkish J Med Sci. 2019;49:361–7.
[21] Neamati F, Firoozeh F, Saffari M, Zibaei M. Virulence Genes and Antimicrobial Resistance Pattern in Uropathogenic Escherichia coli Isolated From Hospitalized Patients in Kashan , Iran. Jundishapur J Microbiol. 2015;8(2):e17514.
[22] Malekzadegan Y, Khashei R, Sedigh Ebrahim-Saraie H, Jahanabadi Z. Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients 11 Medical and Health Sciences 1108 Medical Microbiology. BMC Infect Dis. 2018;18(1):1–9.
[23] Jadhav S, Hussain A, Devi S, Kumar A, Parveen S, Gandham N, et al. Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India. PLoS One. 2011;6(3):e78063.
[24] Kot B, Wicha J, Grużewska A, Piechota M, Wolska K, Obrębska M. Virulence factors, biofilm-forming ability, and antimicrobial resistance of urinary Escherichia coli strains isolated from hospitalized patients. Turkish J Med Sci. 2016;46(6):1908–14.
[25] Olorunmola FO, Kolawole DO, Lamikanra A. Antibiotic resistance and virulence properties in escherichia coli strains from cases of urinary tract infections. African J Infect Dis. 2013;7(1):1–7.
[26] Wang Y, Zhao S, Han L, Guo X, Chen M, Ni Y, et al. Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China. J Antibiot (Tokyo). 2014;67(12):799–805.
[27] Tabasi M, Asadi Karam MR, Habibi M, Yekaninejad MS, Bouzari S. Phenotypic Assays to Determine Virulence Factors of Uropathogenic Escherichia coli (UPEC) Isolates and their Correlation with Antibiotic Resistance Pattern. Osong Public Heal Res Perspect. 2015;6(4):261–8.
[28] Miranda-Estrada LI, Ruíz-Rosas M, Molina-López J, Parra-Rojas I, González-Villalobos E, Castro-Alarcón N. Relationship between virulence factors, resistance to antibiotics and phylogenetic groups of uropathogenic Escherichia coli in two locations in Mexico. Enferm Infecc Microbiol Clin. 2017;35(7):426–33.
[29] Oliveira FA, Paludo KS, Arend LNVS, Farah SMSS, Pedrosa FO, Souza EM, et al. Virulence characteristics and antimicrobial susceptibility of uropathogenic Escherichia coli strains. Genet Mol Res. 2011;10(4):4114–25.
[30] Shakhatreh MAK, Swedan SF, Al-Odat MA, Khabour OF. Uropathogenic Escherichia coli (UPEC) in Jordan: Prevalence of urovirulence genes and antibiotic resistance. J King Saud Univ - Sci. 2019;31(4):648–52.
[31] Velasco M, Horcajada JP, Moreno-martinez A, Vila J, Martinez A, Ruiz J, et al. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis. 2001;33:1682–1386.
[32] Hacker J, Blum-Oehler G, Muhldorfer I, Tschape H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol. 1997;23(6):1089–97.
[33] Vila J, Simon K, Ruiz J, Horcajada JP, Velasco M, Barranco M, et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis. 2002;186(7):1039–42.
[34] Chung The H, Boinett C, Pham Thanh D, Jenkins C, Weill FX, Howden BP, et al. Dissecting the molecular evolution of fluoroquinolone-resistant Shigella sonnei. Nat Commun. 2019;10:4828.
[35] Fortie L-C, Sekulovic O. Importance of prophages to evolution and virulence of bacterial pathogens. Virulence. 2013;4(5):354–65.
[36] Soto SM, Anta MTJ De, Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli bt SOS-dependant or -independant pathways, respectively. Antimicrob Agents Chemother. 2006;50(2):649–53.
[37] Johnson TJ, Nolan LK. Pathogenomics of the Virulence Plasmids of Escherichia coli. Microbiol Mol Biol Rev. 2009;73(4):750–74.
[38] Villa L, García-Fernández A, Fortini D, Carattoli A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother. 2010;65(12):2518–29.
[39] da Silva GJ, Mendonça N. Association between antimicrobial resistance and virulence in Escherichia coli. Virulence. 2012;3(1):18–28.
[40] L. Martínez J, Baquero F. Interactions among Strategies Associated with Bacterial Infection: Pathogenicity, Epidemicity, and Antibiotic Resistance. Clin Microbiol Rev. 2002;15(4):647–79.
[41] Garcillán-Barcia MP, de la Cruz F. Why is entry exclusion an essential feature of conjugative plasmids? Plasmid. 2008;60(1):1–18.
[42] Szczepanowski R, Braun S, Riedel V, Schneiker S, Krahn I, Pühler A, et al. The 120 592 bp IncF plasmid pRSB107 isolated from a sewage-treatment plant encodes nine different antibiotic-resistance determinants, two iron-acquisition systems and other putative virulence-associated functions. Microbiology. 2005;154(4):1095–111.
[43] Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother. 2009;53(6):2227–38.
[44] Pitout JD, Laupland KB, Church DL, Menard ML, Johnson JR. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 2005;49:4667–70.
[45] Karisik E, Ellington MJ, Livermore DM, Woodford N. Virulence factors in Escherichia coli with CTX-M-15 and other extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother. 2008;61:54–8.
[46] Calhau V, Lin T, Ribeiro G, Mendonca N, Sa Silva G. Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli that cause urosepsis. Clin Microbiol Infect. 2011;17(Suppl 4):S130.
[47] Lee S, Yu JK, Park K, Oh E-J, Kim S-Y, Park Y-J. Phylogenetic groups and virulence factors in pathogenic and commensal strains of Escherichia coli and their association with blaCTX-M. Ann Clin Lab Sci. 2010;40(4):361–7.
[48] Lavigne J-P, Blanc-Potard A-B, Bourg G, Moreau J, Chanal C, Bouziges N, et al. Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases. Clin Microbiol Infect. 2006;12(12):1199–206.
[49] Peerayeh SN, Navidinia M, Fallah F, Bakhshi B, Jamali J. Pathogenicity determinants and epidemiology of uropathogenic E . coli ( UPEC ) strains isolated from children with urinary tract infection ( UTI ) to define distinct pathotypes . Biomed Res. 2018;29(10):2035–43.
[50] Slavchev G, Pisareva E, Markova N. Virulence of uropathogenic Escherichia coli. J Cult Collect. 2009;6(2008–2009):3–9.
[51] Beceiro A, Tomás M, Bou G. Antimicrobial Resistance and Virulence : a Successful or Deleterious Association in the Bacterial World ? Clin Microbiol Rev. 2013;26(2):185–230.
[52] Geisinger E, Isberg RR. Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria. J Infect Dis. 2017;215(Suppl 1):9–17.
[53] Shah C, Baral R, Bartaula B, Shrestha LB. Virulence factors of uropathogenic Escherichia coli ( UPEC ) and correlation with antimicrobial resistance. BMC Microbiol. 2019;19:204.
[54] Ramírez-Castillo FY, Moreno-Flores AC, Avelar-González FJ, Márquez-Díaz F, Harel J, Guerrero-Barrera AL. An evaluation of multidrug ‑ resistant Escherichia coli isolates in urinary tract infections from Aguascalientes , Mexico : cross ‑ sectional study. Ann Clin Microbiol Antimicrob. 2018;17:34.
[55] Miranda-estrada LI, Ruíz-rosas M, Molina-lópez J, Parra-rojas I, Gonzalez-Villalobos E, Castro-Alarcon N. Relationship between virulence factors , resistance to antibiotics and phylogenetic groups of uropathogenic Escherichia coli in two locations. Enferm Infecc Microbiol Clin. 2017;35(7):426–33.
[56] Irenge LM, Ambroise J, Bearzatto B, Durant J, Chirimwami RB, Gala J-L. Whole-genome sequences of multidrug- resistant Escherichia coli in South-Kivu Province , Democratic Republic of Congo : characterization of phylogenomic changes , virulence and resistance genes. BMC Infect Dis. 2019;19:137.
[57] Pootong A, Mungkornkeaw N, Norrapong B, Cowawintaweewat S. Phylogenetic background , drug susceptibility and virulence factors of uropathogenic E . coli isolate in a tertiary university hospital in central Thailand. Trop Biomed. 2018;35(1):195–204.
[58] Vagarali MA, Karadesai SG, Patil CS, Metgud SC, Mutnal MB. Haemagglutination and siderophore production as the urovirulence markers of uropathogenic Escherichia coli. Indian J Med Microbiol. 2008;26(1):68–70.
[59] Marrs CF, Zhang L, Foxman B. Escherichia coli mediated urinary tract infections: Are there distinct uropathogenic E. coli (UPEC) pathotypes? FEMS Microbiol Lett. 2005;252(2):183–90.
[60] Shruthi N, Ravikumar, Ravishkukar. Phenotypic Study of Virulence Factors in Escherichia Coli Isolated From Antenatal Cases , Catheterized Patients , and Faecal Flora. J Clin Diagnostic Res. 2012;6(10):1699–703.
[61] Subashchandrabose S, Mobley HLT. Virulence and fitness determinants of uropathogenic Escherichia coli. Microbiol Spectr. 2015;3(4):1–20.
[62] Torres AG, Redford P, Welch RA, Payne SM. TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse. Infect Immun. 2001;69:6179–85.
[63] Marrs CF, Zhang L, Tallman P, Manning S, Somsel P, Raz R, et al. Variations in 10 putative virulence genes among urinary, faecal and peri-urethral Escherichia coli. J Med Microbiol. 2002;51:138–42.
[64] Lloyd AL, Smith SN, Eaton KA, Mobley HLT. Uropathogenic Escherichia coli Suppresses the Host Inflammatory Response via Pathogenicity Island Genes sisA and sisB. Infect Immun. 2009;77(12):5322–33.